BCL2L11 and metabolic dysfunction-associated steatotic liver disease: Compared to healthy participants, BCL2L11 mRNA expression was significantly downregulated, while the mRNA levels of NAGS, HDHD3, and RMND1 were significantly altered in peripheral blood of NAFLD patients (P < 0.01) (Supplementary Fig. 1A).